Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey

被引:33
|
作者
Kang, Sunyoung [1 ,2 ]
Moon, Min Kyong [1 ,3 ]
Kim, Won [1 ,4 ]
Koo, Bo Kyung [1 ,3 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med,Div Endocrinol, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea
[4] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Div Gastroenterol & Hepatol,Dept Internal Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea
基金
新加坡国家研究基金会;
关键词
Hepatic steatosis; Hepatic fibrosis; Muscle strength; Sarcopenia; Insulin resistance; ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; AMERICAN ASSOCIATION; PRACTICE GUIDELINE; BODY-COMPOSITION; SARCOPENIA; DIAGNOSIS; EXERCISE; NAFLD; RISK;
D O I
10.1002/jcsm.12598
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background We investigated the association between muscle strength and the prevalence of advanced fibrosis among individuals with non-alcoholic fatty liver disease (NAFLD) using a nationwide cross-sectional survey. Methods Individuals, 20 to 79 years of age, from the Korean National Health and Nutrition Examination Surveys (KNHANES) from 2014 to 2016 were selected (N = 14 861), with sample weights applied. Muscle strength was quantified as the handgrip strength divided by the body mass index (BMI); low muscle strength (LMS) was defined as the lowest quartile (Q(1)) of the handgrip strength/BMI for our sample population. NAFLD was defined as hepatic steatosis index >36. Advanced fibrosis was defined as a fibrosis-4 index score >= 1.30 (Fibrosis(FIB4)). Results The mean age of the study population was 45.6 +/- 0.2 years, and 42.4% were male. As muscle strength increased, the mean BMI and age decreased accordingly, and the proportions of diabetes, dyslipidaemia, hypertension, and obesity decreased significantly (P < 0.001 for all). In a crude analysis, the LMS was associated with an increased prevalence of NAFLD (odds ratio [OR] 3.62, 95% confidence interval [CI] 3.25-4.03,P < 0.001), which remained significant even after adjustment for age, sex, obesity, insulin resistance, diabetes, hypertension, dyslipidaemia, and high-sensitivity C-reactive protein (OR 1.66, 95% CI 1.28-2.16,P < 0.001). In this logistic regression model, the prevalence of NAFLD decreased by 24% with each quartile increment in muscle strength (OR 0.76, 95% CI 0.68-0.85,P < 0.001). Among individuals with NAFLD (n = 2092), LMS was significantly associated with the presence of advanced fibrosis (Fibrosis(FIB4)) independently of age, sex, obesity, diabetes, hypertension, dyslipidaemia, and high-sensitivity C-reactive protein (OR 1.66, 95% CI 1.01-2.49,P = 0.015), which lost its statistical significance after additional adjustment for insulin resistance. Conclusions Low muscle strength is independently associated with NAFLD. The significant association between LMS and advanced fibrosis in NAFLD may be mediated through insulin resistance.
引用
收藏
页码:1232 / 1241
页数:10
相关论文
共 50 条
  • [1] Association between Muscle Strength and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Korean Nationwide Survey
    Kang, Sunyoung
    Moon, Min Kyong
    Koo, Bo Kyung
    [J]. DIABETES, 2020, 69
  • [2] Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults
    Lee, Sung-Bum
    Kwon, Yu-Jin
    Jung, Dong-Hyuk
    Kim, Jong-Koo
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [3] Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
    Kang, Min Kyu
    Park, Jung Gil
    Kim, Min Cheol
    [J]. YONSEI MEDICAL JOURNAL, 2020, 61 (10) : 860 - 867
  • [4] Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease
    Kang, Min Kyu
    Park, Jung Gil
    Lee, Heon Ju
    Kim, Min Cheol
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (09) : 1633 - 1640
  • [5] Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
    Moon, Joon Ho
    Koo, Bo Kyung
    Kim, Won
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (04) : 964 - 972
  • [6] Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
    Guo, Wen
    Zhao, Xin
    Miao, Mengyuan
    Liang, Xiuru
    Li, Xiaona
    Qin, Pei
    Lu, Jing
    Zhu, Wenfang
    Wu, Juan
    Zhu, Chen
    Xu, Nianzhen
    Zhang, Qun
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [7] External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients
    Jun, Dae Won
    Kim, Sang Gyune
    Park, Sang Hoon
    Jin, So-Young
    Lee, Ji Sung
    Lee, Jin-Woo
    Kim, Moon Young
    Choi, Dae Hee
    Cho, Yong Kyun
    Yeon, Jong Eun
    Sohn, Joo Hyun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (05) : 1094 - 1099
  • [8] Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
    Shin, Hee Kyung
    Park, Jeong Hwan
    Yu, Jung Hwan
    Jin, Young-Joo
    Suh, Young Ju
    Lee, Jin-Woo
    Kim, Won
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
    Hee Kyung Shin
    Jeong Hwan Park
    Jung Hwan Yu
    Young-Joo Jin
    Young Ju Suh
    Jin-Woo Lee
    Won Kim
    [J]. Scientific Reports, 11
  • [10] Noninvasive diagnosis of advanced fibrosis in non-alcoholic fatty liver disease
    Li, Shuang
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 406 - 406